Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking

P Makvandi, M Chen, R Sartorius, A Zarrabi… - Nano Today, 2021 - Elsevier
Humans are exposed to nanoscopical nanobiovectors (eg coronavirus SARS-CoV-2) as
well as abiotic metal/carbon-based nanomaterials that enter cells serendipitously or …

[HTML][HTML] Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases

S Kakavandi, I Zare, M VaezJalali, M Dadashi… - Cell Communication and …, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …

Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy

SF Masre, NF Jufri, FW Ibrahim… - Reviews in medical …, 2021 - Wiley Online Library
Understanding the molecules that are essential for severe acute respiratory syndrome
coronavirus‐2 (SARS‐CoV‐2) entry can provide insights into viral infection and …

Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials

A Aljuhani, O Albalawi, R Albalawi… - Cell Biology …, 2023 - Wiley Online Library
Since the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread as a new strain of coronavirus disease (COVID‐19) and progressed as a global …

[HTML][HTML] Mitochondria and mitochondrial DNA: key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19

JJ Valdes-Aguayo, I Garza-Veloz, JI Badillo-Almaraz… - Medicina, 2021 - mdpi.com
Background and Objectives. The importance of mitochondria in inflammatory pathologies,
besides providing energy, is associated with the release of mitochondrial damage products …

[HTML][HTML] Anti-SARS-CoV-2 vaccines and monoclonal antibodies facing viral variants

A Chaqroun, C Hartard, E Schvoerer - Viruses, 2021 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is genetically variable,
allowing it to adapt to various hosts including humans. Indeed, SARS-CoV-2 has …

[HTML][HTML] Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

K Shionoya, M Yamasaki, S Iwanami, Y Ito… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and
economic damage worldwide and effective drugs that prevent or cure COVID-19 are …

Silver nanoparticles against SARS-CoV-2 and its potential application in medical protective clothing–a review

T Ahmed, RT Ogulata… - The Journal of The Textile …, 2022 - Taylor & Francis
Abstract Coronavirus-2 (SARS-CoV-2), commonly known as Covid-19, has turned into a
worldwide menace, causing death to millions of people. Coronavirus-2 transmits primarily by …

Molecular communications in viral infections research: Modeling, experimental data, and future directions

MT Barros, M Veletić, M Kanada… - … , Biological and Multi …, 2021 - ieeexplore.ieee.org
Hundreds of millions of people worldwide are affected by viral infections each year, and yet,
several of them neither have vaccines nor effective treatment during and post-infection. This …

[HTML][HTML] Clinical features, diagnosis and treatment of COVID-19

J Ali, Q Ali, MM Hafeez, A Malik - Biological and Clinical Sciences …, 2020 - bcsrj.com
The COVID-19 has affected worldwide population at every level from advance to under
developed countries and also majorly affected clinical microbiology labs. This critique …